This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Sensus Healthcare Inc. (noninvasive skin cancer treatment) netted $11.8mm through its initial public offering of 2.3mm common shares (including the overallotment) at $5.50. Investors also received three-year warrants to buy 2.3mm shares at $6.75. The company originally intended to sell 1.8mm shares at $10-12 when it first set a range in March, but then modified the S-1 filing to reflect a new range of 1.75mm shares at $6.25 a month before closing the offering.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?